Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase III trialYunpeng Yang, Wenfeng Fang, Shou’an Ren et al.|Signal Transduction and Targeted Therapy|2023Cited by 32
Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic CancerYongdong Guo, Haichuan Su, Ronglin Wang et al.|Frontiers in Immunology|2021Cited by 29
Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in ChinaRui Hua, Junqi Niu, Fei Kong et al.|Infectious Diseases and Therapy|2023Cited by 6
Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in ChinaRui Hua, Junqi Niu, Fei Kong et al.|Research Square|2023Cited by 1